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Abstract
Cassia tora L. seeds have previously been reported to reduce blood glucose level in human and animals with diabetes. In the present study,
the effects of Cassia tora L. seed butanol fraction (CATO) were studied on postprandial glucose control and insulin secretion from the pancreas
of the normal and diabetic rats. Diabetes was induced by an i.p. injection of Streptozotocin (55 mg/kg BW) into the male Sprague-Dawley rats.
The postprandial glucose control was monitored during a 240 min-period using a maltose loading test. In normal rats, rats fed CATO (20 mg/100
g BW/d) showed lower postprandial glucose levels in all the levels from 30 min up to 180 min than those in the control rats without CATO 
(p<0.05). In diabetic rats, those levels in the CATO group seemed to be lower during the 30~180 min, but only glucose level at 30 min showed
significant difference compared to that in the control group. Moreover, CATO delayed the peak time of the glucose rise in both normal and diabetic
rats in the glucose curves. On the other hand, when CATO was administered orally to the diabetic rats for 5 days, 12 hr fasting serum glucose
level was decreased in the diabetic rats (p<0.05). Degree of a decrease in 12 hr fasting serum insulin levels was significantly less in the diabetic 
CATO rats as compared to diabetic control rats. On the last day of feeding, β cells of the pancreas were stimulated by 200 mg/dL glucose through
a 40 min-pancreas perfusion. Amounts of the insulin secreted from the pancreas during the first phase (11~20 min) and the second phase (21~40
min) in the CATO fed diabetic rats were significantly greater than those in the diabetic control group (p<0.05). These findings indicated that constituents
of Cassia tora L. seeds have beneficial effect on postprandial blood glucose control which may be partially mediated by stimulated insulin secretion 
from the pancreas of the diabetic rats.
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Introduction8)
The seeds of Cassia tora L. have been conventionally used 
throughout the Asian region for several centuries. Its roasted 
seeds have a favorable flavor, so it is used popularly as a tea 
in Korea. Cassia tora L. has been also prescribed in oriental herb 
medicine to treat night blindness, hypertension, hypercholesterolemia, 
and constipation (Ahn, 1998; Kim et al., 1990). It was reported 
that  Cassia tora L. possesses various functional properties 
including antioxidative (Choi et al., 1994; Lim & Han, 1997; 
Na  et al., 2004; Yen et al., 1998), hypoglycemic (Lim et al., 
1995; Lim & Han, 1997), less cadmium-accumulating (Kim et al., 
2002), antimutagenic (Choi et al., 1997), and anticlastogenicity 
(Kim et al., 1998) activities. Cassia tora L. contains many active 
substances, including nor-rubrofusarin, aurantio-obtusin, chryso- 
obtusin, obtusin, emoidin, obrusifolin, chrysophanol, physcion, 
and chryso-obtusin-2-Ο-β-D-glucoside (Jang et al., 2007). A study 
with streptozotocin-induced diabetic rats (Lim et al., 1995) 
reported that 10% of Cassia tora  L. in diet lowered plasma 
glucose, and this lowering effect was as acute as seen even at 
the first week of feeding. They reported that a butanol fraction 
of the methanol extract was the one that decreased plasma 
glucose levels, and this decrease was shown so early even at 
the 4
th day of feeding (Lim & Han, 1997). Recently, Jang et 
al. (2007) suggested that emodin and obtusifolin in Cassia tora 
L. might be the components having antidiabetic functions since 
they exhibited a significant inhibitory activity on advanced 
glycation end products (AGEs) formation. However, this study 
was performed in vitro. In order to claim an herb or agent as 
the therapeutics for the diabetes, the in vivo activity of lowering 
blood glucose should be observed. In addition to that, it would 
be prefer to study effects on the insulin secretion from the 
pancreas in type 1 diabetes mellitus. Process in the insulin 
synthesis and secretion is disregulated and is related with the 
destruction of the β cells in Langerhan’s islets (Gorsuch et al., 
1981; Steele et al., 2004; Weir & Bonner-weir, 2004). Clinically, 
insulin activities have been assessed by peripheral blood insulin 
and C-peptide measurements. However, those measurements may 
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not accurately reflect amounts of insulin secreted directly from 
the pancreas. Over time, there are relatively little studies on 
insulin secretion from the pancreas in type 1 diabetes. Therefore, 
in the present study, type 1 diabetes was induced by destroying 
β cells with Streptozotocin injection and direct insulin secretion 
was evaluated using a pancreas perfusion.
Materials and Methods 
Preparation of Cassia tora L. seeds butanol fraction
Cassia tora L. seeds (cultivated in Youngcheon, Korea) were 
purchased from the local oriental herbs market. The seeds were 
ground into the fine powder and extracted with 85% methanol 
(5 volumes of MeOH) in a stainless steel extraction tank for 
24 hours at room temperature. This methanol mixture was filtered 
in the funnels and centrifuged (4℃, 3000 rpm, 20 min), which 
was repeated three times. All the precipitate was eliminated, and 
the MeOH extract portion was collected and then concentrated 
using a rotary evaporator. This methanol extract was subsequently 
partitioned with hexane (1: 1 by volume) and then with 
dichloromethane (1: 1 by volume) for 24 hours. The aqueous 
layer was further partitioned using butanol (1: 1 by volume) and 
separated into the aqueous layer for 24 hours. Finally, Cassia 
tora L. seeds butanol fraction (CATO) was collected, condensed 
by a rotary evaporator, and freeze-dried.
Animals and diabetes induction
Adult male Sprague-Dawley rats, weighing 330-390 g, were 
obtained from an animals company (Daehan Biolink Co., Ltd, 
Korea) and placed in the individual cage in order to acclimate 
to the environment for 7 days. Animals were maintained under 
the condition controlled with a 12 hour light-12 hour dark cycle 
(light in at 06:00 and light out at 18:00), temperature of 25 ±
2℃, and humidity of 50 ± 5%. The commercial rodent pellet 
diet and water were fed ad libitum during the experimental 
period. Diabetes was induced by intraperitoneal injection of 
Streptozotocin (55 mg/kg BW, Sigma Chemical Co., St. Louis, 
MO, USA) dissolved freshly in 0.01 M citrate buffer (pH 4.5). 
Rats showing above 300 mg/dL of 12 hours fasting serum glucose 
level were used for the diabetic groups. All experimental 
procedures were approved by Inje University Animal Care and 
Use Committee (IUACUC) and met all the guidelines in the Care 
and Use of Animals.
Blood glucose control after loading maltose orally
Control of blood glucose was evaluated by an oral maltose 
loading test in order to assess postprandial glycemic control. 
Normal (n=12) and diabetic (n=12) rats were fasted for 12 hours 
overnight. They were divided into two groups of CATO group 
and control group (CONT). Rats in the CATO group were orally 
administrated 2 g of maltose per kg body weight and 20 
mg/ml/100 g BW of Cassia tora L. seeds butanol fraction. In 
the CONT group, rats were orally administrated the same dosage 
of maltose and water. Blood samples were collected from the 
tail vein at 0, 30, 60, 90, 120, 180, and 240 min after loading 
maltose. Serum was separated from blood by centrifuge (3000 
rpm, 10 min), and serum glucose levels were determined by 
glucose oxidase method using a kit (Sigma Chemical Co., Saint 
Louis, MO, USA). 
Fasting serum glucose and insulin levels 
Three days after performing the maltose loading test, rats in 
the CATO groups were fed Cassia tora L. butanol extract (20 
mg/100 g BW/d) for 5 days using a gavage.  Only water was 
supplied for rats in the CONT group. After rats were fasted for 
12 hours overnight, blood samples were collected from the tail 
vein at day 0 for the initial levels and day 5 for the final levels. 
Serums were separated and frozen at -20℃ for the glucose and 
insulin assays.
Insulin secretion from the pancreas 
At the end of the CATO feeding (day 5), rats were anesthetized 
with an intraperitoneal injection of urethane (300 mg/100 g BW). 
Pancreas was carefully removed and perfused to determine 
amounts of insulin secreted directly from the pancreas. The 
perfusate preparation and pancreas perfusion procedure have been 
shown in other studies (Choi, 2000; Choi, 2005). Briefly, the 
components of the perfusate were as follows: 0.18% bovine 
serum albumin (fraction V), 4.00% of dextran, 0.110 M of CaCl2, 
0.154 mM of KCl, KH2PO4, NaHCO3, NaCl, and MgSO4. The 
perfusate was continually oxygenated with a 95% O2-5% CO2 
gas and maintained at 37℃ using a circulating water bath. Inflow 
rate of the perfusate was constantly maintained at 5 ml/min using 
a perfusion apparatus (Cole-Parmer Inst. Co., Chicago, IL, USA). 
During the first 0~10 min of the equilibration period, glucose 
was not included in the perfusate. During the 11~40 min of the 
perfusion period, glucose (200 mg/dL) was infused into the 
perfusate using a side arm-infusion pump (Harvard Apparatus, 
Holliston, MA, USA), thus the pancreas was stimulated by the 
glucose level of hyperglycemic condition. The inflow began via 
the heparinized celiac arterial cannula. Total outflow from the 
pancreas was collected via a heparinized portal vein cannula 
during the total 40 min period with 2~5 min time intervals, and 
volumes of these effluent samples were measured. The effluent 
samples were kept on ice until centrifuged (3000 rpm, 4℃, 20 
min). The supernatants of these samples were decanted and 
frozen at -20℃ until insulin amounts were determined.242 Antidiabetic function of Cassia tora L. seeds
Table 1. Postprandial glucose levels in normal and diabetic rats administered Cassia tora. L. butanol fraction
Serum glucose level (mg/dL)
0 min 30 min 60 min 90 min 120 min 180 min 240 min
Normal rats
CONT (n=6)  73.6 ± 6.5
a 144.6 ± 8.4
a 137.8 ± 6.3
a 122.0 ± 8.0
a 106.4 ± 7.4
a  96.0 ± 7.2
a  84.0 ± 9.1
a
CATO (n=6)  77.3 ± 2.3
a  84.7 ± 7.6
b,* 106.5 ± 2.2
b,*  96.7 ± 3.6
b,*  88.2 ± 3.5
b,*  74.5 ± 2.0
b,*  70.5 ± 1.8
a
Diabetic rats
CONT (n=6) 339.2 ± 15.0
b 622.4 ± 14.0
c 609.6 ± 36.9
c 582.0 ± 30.5
c 539.8 ± 24.0
c 471.4 ± 17.9
c 417.7 ± 19.2
b
CATO (n=6) 394.0 ± 25.7
b 508.0 ± 34.0
d,* 552.3 ± 67.8
c 516.3 ± 43.6
c 480.7 ± 20.7
c 445.3 ± 14.8
c 438.3 ± 9.8
b
Values  are  mean ± SE. 
n:  number  of  rats  in  the  group
Within  the  same  column,  values  with  different  superscripts  are  significantly  different  by  ANOVA  and  Scheffé test  at  p<0.05. 
*p <0 . 0 5  c o m p a r e d  t o  t h e  v a l u e  o f  t h e  c o r r e s p o n d in g  C O N T  u s i n g  a  S tudent’s  t-test 
CONT:  control  group  of  rats  orally  administrated  maltose  (0.2  g/ml/100  g  BW)
CATO:  group  of  rats  orally  administrated  maltose  (0.2  g/ml/100  g  BW)  and  Cassia  tora.  L.  butanol  fraction  (20  mg/ml/100  g  BW)
Table 2. Body weights in normal and diabetic rats administered Cassia tora L.
butanol fraction for 5 days
Normal rats Diabetic rats
CONT
(n=6)
CATO
(n=6)
CONT
(n=6)
CATO
(n=6)
Initial body weight (g) 333.2 ± 17.7
a 388.7 ± 4.6
a 340.8 ± 19.7
a 335.2 ± 17.4
a
Final body weight (g) 348.7 ± 13.7
a 380.7 ± 5.2
a 321.3 ± 17.1
a 312.4 ± 11.1
b
Values  are  mean ± SE. 
n:  number  of  rats  in  the  group
Within the same row, values with different superscripts are significantly different by 
ANOVA  and  Scheffé test  at  p<0.05.
CONT:  Rats  were  fed  on  pellet  diet  and  water  for  5  days. 
CATO: Rats were fed on pellet diet and administered Cassia tora. L.butanol fraction 
( 2 0  m g / 1 0 0  g  B W / d )  f o r  5  d a y s . 
Glucose and insulin measurements
Glucose levels in the serum were determined by a kit (Sigma 
Chemical Co., Saint Louis, MO, USA). Insulin amounts in the 
serum and perfusion effluent samples were determined by the 
rat insulin radioimmunoassay kit (Linco Research, Inc. Saint 
Charles, MO, USA). Radioisotope detection was carried out using 
an auto gamma counting system (Hewlett Packard Instrument 
Co, Palo Alto, CA, USA).   The cpms were counted from 
triplicated standard tubes and duplicated sample tubes, and the 
count of the nonspecific binding was subtracted. The bound/free 
triplicates for each point on the standard curve were averaged 
and plotted versus insulin amounts. For each sample duplicate, 
the bound/free was read off as insulin amounts (ng/ml) from the 
standard curve. Insulin secretion rates (ng/min) were calculated 
by using the measured perfusate effluent flow rate (ml/min).
Statistical analysis 
All data were expressed as means ± SE. Student's t-test or one 
way ANOVA followed by Scheffé  test was conducted to 
determine statistical significances in difference at p<0.05 among 
mean values of the groups. 
Results 
Blood glucose control after loading maltose orally 
Blood glucose levels after loading maltose orally in the normal 
and diabetic rats were shown in Table 1. Serum glucose levels 
of normal control rats were 73.6 ± 6.5 mg/dL at 0 min. After 
30 min, serum glucose was increased up to 144.6 ± 8.4 mg/dL, 
and then declined to 84.0 ± 9.1 mg/dL at the end of 240 
min-period. In the normal CATO rats, serum glucose level at 
0 min was 77.3 ± 2.3 mg/dL and increased up to 106.5 ± 2.2 
mg/dL at 60 min, and then declined to 70.5 ± 1.8 mg/dL at 240 
min. The peak time in the CATO group was 60 min, while it 
was 30 min in the CONT group; showing a slower uprising in 
the glucose curve due to CATO. These normal CATO rats 
showed lower serum glucose levels from 30 min up to 180 min 
than the CONT rats (p<0.05). In the diabetic rats, serum glucose 
level in the CONT group was 339.2 ± 15.0 mg/dL at 0 min, and 
increased up to 622.4 ± 14.0 mg/dL at 30 min, and then declined 
to 417.7 ± 19.2 mg/dL at 240 min. In the diabetic CATO group, 
serum glucose level was 394.0 ± 25.7 mg/dL at 0 min, 552.3
± 67.8 mg/dL at 60 min, and then declined to 438.3 ± 9.8 mg/dL 
at 240 min. Therefore, the peak time in the CATO group was 
60 min, while it was 30 min in the CONT group, showing a 
slower uprising in the glucose curve. The serum glucose levels 
at 30 min were significantly different between the diabetic CONT 
group and diabetic CATO group (p<0.05). Therefore, the 
postprandial rise of glucose was significantly reduced and 
delayed by CATO in diabetic rats. 
Body weights, fasting serum glucose, and fasting serum insulin 
levels 
Initial body weights were similar in normal and diabetic rats 
as shown in Table 2. There was no significant difference in the 
final body weight between the CONT and CATO groups in 
normal rats. The final body weight in the diabetic CATO group 
was low significantly among all the groups by ANOVA and 
Scheffé test, but this value did not differ significantly compared 
to the value of the diabetic CONT group by a Student’s t-test. Jeongsu Nam and Hyunju Choi 243
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Fig. 1. Fasting serum glucose levels in normal and diabetic rats administered 
Cassia tora L. butanol fraction for 5 days. Values are mean ± SE. Number of 
rats  is  6  per  each  group.  Bars  with  different  letters  are  significantly  different  by 
ANOVA and Scheffé test at p<0.05. CONT: Rats were fed on pellet diet and water 
for 5 days. CATO: Rats were fed on pellet diet and administered Cassia tora. L.
butanol  fraction  (20  mg/100  g  BW/d)  for  5  days. 
Table 3. Fasting serum insulin levels in normal and diabetic rats administered 
Cassia tora L. butanol fraction for 5 days
Normal rats Diabetic rats
CONT
(n=6)
CATO
(n=6)
CONT
(n=6)
CATO
(n=6)
Initial s-insulin 
(ng/ml)
0.759 ± 0.056
a 0.787 ± 0.042
a 0.474 ± 0.053
b 0.370 ± 0.020
b
Final s-insulin 
(ng/ml)
0.615 ± 0.097
a 0.621 ± 0.055
a 0.288 ± 0.038
b 0.289 ± 0.013
b 
Values  are  mean ± SE. 
n:  number  of  rats  in  the  group
Within the same row, values with different superscripts are significantly different by 
ANOVA  and  Scheffé test  at  p<0.05. 
CONT:  Rats  were  fed  on  pellet  diet  and  water  for  5  days. 
CATO: Rats were fed on pellet diet and administered Cassia tora. L. butanol fraction 
(20  mg/100  g  BW/d)  for  5  days. 
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Fig. 2. Insulin amounts secreted from the pancreas of the normal rats 
administered Cassia tora L. butanol fraction for 5 days. Values are mean ± SE. 
Number of rats is 6 per each group. There were no significant differences between 
the CONT and CATO by Student’s t-test. 0-10
 min: perfusion period of no glucose 
stimulation.  11-20
  and  21-40  min:  perfusion  period  of  200  mg/dL  glucose 
stimulation. CONT: Rats were fed on pellet diet and water for 5 days. CATO: Rats 
were fed on pellet diet and administered Cassia tora. L. butanol fraction (20 mg/100 
g  BW/d))  for  5  days. 
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Fig. 3. Insulin amounts secreted from the pancreas of the diabetic rats 
administered Cassia tora L. butanol extract for 5 days. Values are mean ± SE. 
Number of rats is 6 per each group. Bars with an asterisk are significantly different 
compared to the value of CONT by Student’s t-test at p<0.05. 0-10
 min: perfusion 
p erio d  o f n o g luco se stim u lation . 1 1-2 0
  and  21-40  min:  perfusion  period  of  200 
mg/dL glucose stimulation.  CONT: Rats were fed  on pellet diet an d  w ater for 5 
days. CATO: Rats were fed on pellet diet and administered Cassia tora. L.butanol 
f r a c t i o n  ( 2 0  m g / 1 0 0  g  B W / d )  f o r  5  d a y s . 
Fasting serum glucose levels were shown in Fig. 1. In normal 
rats, the initial and final fasting serum glucose levels were similar 
between CONT and CATO groups. In diabetic rats, the initial 
fasting serum glucose levels were different between CONT and 
CATO groups (358.17 ± 24.62 mg/dL and 434.80 ± 23.69 mg/dL, 
respectively). The final serum glucose level was 399.17 ± 18.83 
mg/dL in diabetic CONT group, and 422.20 ± 7.12 mg/dL in 
diabetic CATO group. Therefore, serum glucose levels were 
increased in diabetic CONT group after 5 days of feeding, while 
those levels were decreased in diabetic CATO group. Fasting 
serum insulin levels were shown in Table 3. Initial and final 
serum insulin levels were similar in the CONT and CATO groups 
in normal rats. In the diabetic rats, the initial serum insulin levels 
did not differ significantly between the diabetic CONT and 
diabetic CATO groups (0.474 ± 0.053 ng/ml and 0.370 ± 0.020 
ng/ml, respectively). The final serum insulin levels were also 
similar between the CONT (0.288 ± 0.038 ng/ml) and CATO 
groups (0.289 ± 0.013 ng/ml). However, change in the fasting 
serum insulin levels during the 5 day feeding period was -0.186
± 0.046 ng/ml in the CONT group, which was a 39% decrease 
compared to the initial level. In the diabetic CATO group, change 
in the fasting serum insulin levels was -0.083 ± 0.02 ng/ml 
(p<0.05) during the same feeding period, which was a 22% 
decrease from the initial level. These data demonstrated that 
CATO may affect to reduce less in serum insulin in the diabetic 
rats. 
Insulin secretion amounts from the pancreas
The amounts of insulin secretion during the 40 min of perfusion 
period were shown in Fig. 2 and Fig. 3. In normal rats, the 
amounts of insulin secretion during the first 10 min of the 
equilibration period were comparable between the CONT and 
CATO groups.  During the next 11~20 min of the first secretory 
phase and the following 21~40 min of the second secretory phase, 
significant differences in insulin amounts were not seen between 
the CONT and CATO groups. Therefore, CATO may not 244 Antidiabetic function of Cassia tora L. seeds
influence the insulin secretion from the pancreas of normal rats. 
However, the insulin secretion was quite different in the groups 
of diabetic rats. The amounts of insulin secretion during the first 
10 min were similar as 3.07 ± 0.53 ng/300 g body weight in 
the CONT and 3.37 ± 2.24 ng/300 g body weight in the CATO 
group. During the next 11~20 min of the first phase, the amount 
of insulin was 6.17 ± 2.34 ng/300 g body weight in the CONT 
group and 12.11 ± 0.44 ng/300 g body weight in the CATO group 
(p<0.05). The pancreas in the CATO group secreted insulin about 
two times greater than that in the CONT group during this early 
perfusion period. During the period of 21~40 min, the amount 
of insulin secretion was 1.94 ± 0.97 ng/300 g body weight in 
the CONT group and 6.18 ± 0.50 ng/300 g body weight in the 
CATO group (p<0.05). Therefore, the pancreas in the CATO 
group secreted insulin about more than three times greater than 
that in the CONT group during this second secretory phase. These 
data showed that CATO significantly stimulated the insulin 
secretion from the pancreas in the diabetic rats, although the 
absolute amount was still in the lower range when compared 
to those in the non-diabetic normal rats. 
Discussion
Primary therapeutic purpose for treating type 1 diabetes is to 
reduce blood glucose levels. Various hypoglycemic medications 
have been prescribed in the hospitals and clinics; α-glycosidase 
inhibitor such as acarbose and miglitol, or insulin secretagogue 
such as sulfonylurea. Other medications are metformin and 
thiazolidinedione, which promote insulin sensitivity and reduce 
hepatic glucose output. However, these hypoglycemic medications 
may have some side effects. In the case of type 1 diabetes, 
patients who have been treated with insulin therapy for the 
extended period complained about pain, bruise, and even insulin 
allergy such as urticaria, angioedema, pruritus, rash, and dyspnea 
(Lee, 2008). Therefore, natural medicinal foods that may have 
antidiabetic functions but do not have harmful side effects have 
been focused and searched in Korea (Park & Wang, 2008). One 
survey study reported that 70.8% of type 2 diabetes patients had 
consumed functional foods, and the most frequent ingested food 
item was silkworm, followed by ginseng, black bean, and pine 
tree leaves in order (Kim et al., 2000). Recently, kinds of 
polysaccharides from the edible plants have been reported as 
antidiabetic agents (Kim et al., 2008; Park et al., 2007). Lim 
et al. (1995) reported that Cassia tora seeds feeding for one week 
reduced blood glucose in the streptozotocin-induced diabetic rats, 
and they suggested that Cassia tora butanol fraction might be 
the potent fraction among other fractions of the methanol extracts 
(Lim & Han, 1997). 
In the present study, positive effect of CATO on blood glucose 
control after loading maltose orally was clearly seen in the normal 
rats. Postprandial serum glucose increment was 96.5% from the 
baseline of the glucose level at 0 min in the normal CONT group. 
However, it was only 9.5% in the normal CATO group. Besides, 
CATO slowed a rise of glucose until 60 min, while a sharp rise 
was seen at the 30 min in the normal CONT group (Table 1). 
In the diabetic rats, serum glucose increment was 83.4% from 
the baseline of the glucose level at 0 min in the CONT group. 
However, it was 28.9% increment in the diabetic CATO group 
(Table 1). Delaying peak time in the blood glucose curve seems 
to appear in the diabetic rats. Therefore, CATO seems to be 
beneficial to control the postprandial blood glucose. 
Changes in body weight were not seen in the normal rats (Table 
2). However, in the diabetic rats, 5.7% of the body weight was 
reduced in the CONT group and 6.8% in the CATO group. In 
general, body weight loss is a common symptom in the diabetic 
rats (Kim et al., 2008; Lim & Han, 1997). Fasting serum glucose 
levels in the diabetic rats were increased in the CONT group 
after 5 days of feeding and the degree of increase in glucose 
was less in the CATO group (Fig. 1). In the diabetic rats, change 
in fasting serum insulin was -39.2% in the CONT group while 
it was -21.9% in the CATO group (p<0.05). Therefore, the effect 
of CATO on lessening the blood glucose rise was seen even 
with a short feeding period of 5 days, and might be related with 
a degree of decrease in the fasting serum insulin levels.
We examined the effects of CATO on the direct insulin 
secretion from the pancreas in normal and diabetic rats. There 
was no significant difference in insulin amounts during the 0~10 
min, 11~20 min, and 21~40 min of perfusion periods between 
the CATO group and CONT group in normal rats (Fig. 2). 
However, in the diabetic rats, CATO increased insulin secretion 
during the 11~20 min and 21~40 min periods (Fig. 3). Insulin 
amounts during the first 0~10 min were not different between 
the diabetic CATO and diabetic CONT groups. This first 10 min 
was a period of perfusion without glucose stimulation, and insulin 
secretion in this period was from the stored pool in the secretory 
vesicles of the β cells (Curry & Maclachlan, 1987). The next 
11~40 min was a period of perfusion with glucose stimulation. 
The stimulation-secretion coupling process in the pancreatic β
-cells is affected by glucose (Curry, 1986; Rossetti et al., 1990; 
Yki-Jarvenen, 1992) as well as amino acids (Strandgaard & 
Curry, 1998), manganase (Baly et al., 1984), magnesium (Curry 
et al., 1977), calcium (Choi, 1997), fatty acid (Brockman, 1982; 
Nolan et al., 2006), cinnamic acid (Adsakwattana et al., 2008; 
Yibchok-anun et al., 2008), and oleanolic acid (Hsu et al., 2006).
 
Therefore, the biochemical environment of the pancreas may 
modulate the insulin secretion from the pancreas (Pørksen et al., 
2002). In addition to that, the nervous system is involved in the 
regulation of insulin secretion from the pancreas (Ahren et al., 
1987; Ahren & Taborsky, 1986; Choi, 2000; Curry, 1983; Curry, 
1984; Lee et al., 1993; Lee et al., 1989). Therefore, the neural 
inputs could be important in regulation of the insulin secretion 
from the pancreas. Other factors influencing the insulin secretion 
could be hormones (Ahren et al., 1986; Ahren et al., 1987; Curry 
et al., 1982). The method used in this study was able to determine 
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pancreas without any above primary and secondary metabolic, 
neural, and hormonal influences on the secretory process, since 
our perfusion method allows the anatomical isolation. In our 
study, the amount of insulin secreted from the pancreas during 
the first secretory phase was greater as 1.96 times in the CATO 
group compared with that in the CONT group (p<0.05). 
Moreover, the amount of insulin secreted from the pancreas 
during the second secretory phase was also greater as 3.19 times 
in the CATO group compared with that in the CONT group 
(p<0.05). Even though absolute amount of insulin in the diabetic 
CATO group is not sufficient to cure diabetes, these data suggest 
that intakes of CATO might improve pancreatic β cells response 
to the high levels of glucose challenge. Our study could not 
directly determine how CATO affects the insulin secretion 
activity in the β cells of the pancreas. Recently, it was reported 
that β cell failure shown in diabetes could be restored by more 
expression of insulin receptor substrate-2 (Irs2) since Irs2 
mediates replication and survival of the β cells (Hennige et al., 
2003; Park et al., 2006). Other possible explanation is that CATO 
might protect some pancreatic β-cells from further deterioration 
or even enhancement of the remaining β cell function. While 
this short-term study has implications in terms of reducing 
postprandial blood glucose levels and increasing insulin 
secretion, studies on the long-term effects of CATO may be 
worthy to perform in the future.
In conclusions, our results show that butanol fraction from the 
Cassia tora L. seeds has a beneficial effect for the postprandial 
blood control, thus Cassia tora L. seeds can be used as a diet 
supplement with a meal. Further studies with pancreatic β-cells 
are needed to clarify its effects and the mechanism involved.
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